rhodamine 123 has been researched along with Neuroendocrine Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, M; Eriksson, B; Långström, B; Lukinius, A; Watanabe, Y; Wu, F | 1 |
1 other study(ies) available for rhodamine 123 and Neuroendocrine Tumors
| Article | Year |
|---|---|
A mechanism behind the antitumour effect of 6-diazo-5-oxo-L-norleucine (DON): disruption of mitochondria.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Apoptosis; Diazooxonorleucine; Humans; Microscopy, Electron; Mitochondria; Neuroendocrine Tumors; Rhodamine 123; Tetrazolium Salts; Tumor Cells, Cultured | 1999 |